Clinical Study to evaluate the Herbal formulation for its action in promoting Healthy hair growth and minimizing Hair losses - NI

Plantayu life science LLP0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年7月25日

试验速览

暂无简介。

•1.Age from 18 - 60 yrs
•2.Male or female
•3.Willing to provide voluntary written informed consent.
•4.Patients having self-reported thinning or hair loss for more than 6 months prior to screening
•5.Patient clinically confirmed to have hair loss or thinning though physical exam ( for female pattern hair loss Savin Classification score of I 2-II 1,[4] for male pattern hair loss Norwood-Hamilton classification score I, II, III) [5]
•6.Patient willing to maintain same hair style, hair color, and hair regimen throughout the study and use mild non medicated shampoo during the study period.
•7.Women of child bearing age willing to adopt medically sound method of birth control during the trial period.

•1.Clinical diagnosis of alopecia areata or scarring forms of alopecia or hair loss due to disease, injury or medical therapy
•2.Patient hypersensitive to study product or hair dye and its component.
•3.History of hair transplant.
•4.Patients with diagnosed organic disease of scalp with dermatological origin (other than mild to moderate dandruff determined by Adherent Scalp Flaking Score) like psoriasis, atopic dermatitis, skin cancer, eczema, sun damage, seborrheic dermatitis which requires medication.
•5.Pregnant or lactating women
•6.Diagnosis of organic diseases including Uncontrolled diabetes mellitus (DM), endocrinal disorder, Hypertension, neoplastic, severe cardiovascular diseases, renal insufficiency, psychiatric disorders, iron deficiency, coagulopathies etc or on any medication that can cause potential hair loss or affects hair growth.
•7.Refusal to provide informed consent

发起方

Plantayu life science LLP